Eugene Braunwald
Brigham and Women's Hospital
7 papers in the Anchorcite directory, published between 1992 and 2015, cited 41,892 times in total.
ORCID profileResearch topics
- Acute Myocardial Infarction Research · 4 papers
- Lipoproteins and Cardiovascular Health · 3 papers
- Cancer, Lipids, and Metabolism · 2 papers
- Bariatric Surgery and Outcomes · 1 paper
- Body Contouring and Surgery · 1 paper
- Minimally Invasive Surgical Techniques · 1 paper
Frequent co-authors
- Marc Alan Pfeffer · 3 papers
- Jean Lucien Rouleau · 3 papers
- Stephen D. Wiviott · 3 papers
- Lemuel A. Moyé · 2 papers
- John D. Rutherford · 2 papers
- Barry R. Davis · 2 papers
- Carolyn H. McCabe · 2 papers
- Witold Rużyłło · 2 papers
Papers
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine · 1996 · 7,419 citations
BACKGROUND: In patients with high cholesterol levels, lowering the cholesterol level reduces the risk of coronary events, but the effect of lowering cholesterol levels in the majority of patients with coronary disease, who have average levels, is less clear. METHODS:…
- Bariatric SurgeryJAMA · 2004 · 6,892 citations
CONTEXT: About 5% of the US population is morbidly obese. This disease remains largely refractory to diet and drug therapy, but generally responds well to bariatric surgery. OBJECTIVE: To determine the impact of bariatric surgery on weight loss, operative mortality…
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine · 2007 · 6,831 citations
BACKGROUND: Dual-antiplatelet therapy with aspirin and a thienopyridine is a cornerstone of treatment to prevent thrombotic complications of acute coronary syndromes and percutaneous coronary intervention. METHODS: To compare prasugrel, a new thienopyridine, with clopidogrel, we randomly assigned 13,608 patients with…
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine · 1992 · 5,925 citations
BACKGROUND: Left ventricular dilatation and dysfunction after myocardial infarction are major predictors of death. In experimental and clinical studies, longterm therapy with the angiotensin-converting--enzyme inhibitor captopril attenuated ventricular dilatation and remodeling. We investigated whether captopril could reduce morbidity and mortality…
- Edoxaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine · 2013 · 5,259 citations
BACKGROUND: Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known. METHODS: We conducted a randomized, double-blind, double-dummy trial…
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesNew England Journal of Medicine · 2004 · 4,966 citations
BACKGROUND: Lipid-lowering therapy with statins reduces the risk of cardiovascular events, but the optimal level of low-density lipoprotein (LDL) cholesterol is unclear. METHODS: We enrolled 4162 patients who had been hospitalized for an acute coronary syndrome within the preceding 10…
- Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesNew England Journal of Medicine · 2015 · 4,600 citations
BACKGROUND: Statin therapy reduces low-density lipoprotein (LDL) cholesterol levels and the risk of cardiovascular events, but whether the addition of ezetimibe, a nonstatin drug that reduces intestinal cholesterol absorption, can reduce the rate of cardiovascular events further is not known.…
Metadata from OpenAlex (CC0).